Dissolution improvement of binary solid dispersions of erlotinib prepared by one-step electrospray method

Erlotinib hydrochloride, a selective tyrosine kinase inhibitor approved for treatment of non-small cell lung cancer firstly. Erlotinib classified as class II drugs in the Biopharmaceutical Classification System (BCS), which characterized by low solubility and high permeability. The aim of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Jahangiri, Azin, Khalilzad, Fakhronnesa, Barghi, Leila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Methods Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801718/
https://www.ncbi.nlm.nih.gov/pubmed/35111974
http://dx.doi.org/10.1093/biomethods/bpac001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801718/
https://www.ncbi.nlm.nih.gov/pubmed/35111974
http://dx.doi.org/10.1093/biomethods/bpac001

Ejemplares similares